LOADING
Comparing NVIDIA Corporation (NVDA) and Pfizer Inc (PFE) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | NVDA | PFE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $4.92T | $155.3B |
| P/E Ratio | 41.3 | 20.2 |
| Forward P/E | 24.5 | 9.4 |
| PEG Ratio | 0.71 | 13.77 |
| EPS | $4.90 | $1.35 |
| Revenue Growth (YoY) | 73.2% | -1.2% |
| Profit Margin | 55.6% | 12.4% |
| Return on Equity | 101.5% | 8.9% |
| Dividend Yield | 0.02% | 6.25% |
| Beta | 2.33 | 0.39 |
| 52-Week High | $212.17 | $28.75 |
| 52-Week Low | $104.06 | $20.73 |
| Volume | -- | -- |
NVIDIA Corporation is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. NVIDIA Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.